NCT00427687View on ClinicalTrials.gov

Study Evaluating AGG-523 in Subjects With Osteoarthritis

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

February 28, 2007

Study Completion Date

June 30, 2007

Conditions

Osteoarthritis

Interventions

DRUG

AGG-523

Trial Locations (3)

16635

Altoona

33143

Miami

92801

Anaheim

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00427687 - Study Evaluating AGG-523 in Subjects With Osteoarthritis | Biotech Hunter | Biotech Hunter